. 2017 Nov 10;6:1447. Originally published 2017 Aug 14. [Version 2] doi: 10.12688/f1000research.12198.2

Table 1. Type of EMA requested PAS registered in ENCePP by 18 ^th October 2016 by study status (finalized, ongoing or planned).

	Risk Assessment		Effectiveness Evaluation		Drug Utilization		Total
Finalized	42	20%	11	12%	47	35%	81	26%
Ongoing	112	55%	60	64%	59	44%	160	51%
Planned	51	25%	23	24%	27	20%	73	23%
Total	205	100%	94	100%	133	100%	314	100%

Table 1. Type of EMA requested PAS registered in ENCePP by 18 th October 2016 by study status (finalized, ongoing or planned).